Target intelligence / Profile preview

Ankyrin repeat domain 18F, pseudogene (ANKRD18FP)

Target
ANKRD18FP
Molecular classification
Pseudogene, Other
01

Overview

Ankyrin repeat domain 18F, pseudogene (ANKRD18FP) is classified as a pseudogene, meaning that it resembles a protein-coding gene but does not itself encode a functional protein[5][7]. Pseudogenes are typically generated from gene duplication or retrotransposition events that accumulate disabling mutations over time, leading to a loss of protein-coding capability. Although pseudogenes have historically been considered non-functional genomic relics (“junk DNA”), research indicates that some pseudogenes can influence the function and regulation of related protein-coding genes, often through transcriptional or post-transcriptional mechanisms such as serving as competing endogenous RNAs or producing regulatory non-coding RNAs[4]. There is currently no evidence to suggest that ANKRD18FP itself acts as a therapeutic target, receptor, or enzyme, nor that it is directly implicated in specific disease processes, interacts with drugs, or serves as a biomarker[5][6]. The precise biological function, if any, of ANKRD18FP has not been established.

Other names
Ankyrin repeat domain 18F, pseudogeneANKRD18FPHGNC:56404NCBI Gene: 127379688Ensembl: ENSG00000218577
02

Biological functions

Regulation of gene expression (putative, as with pseudogenes in general)Other
03

Disease associations

Other (no direct association with specific diseases identified; pseudogenes in general may play regulatory roles in diseases such as cancer, but no evidence for this specific pseudogene)

Beyond the preview

Go deeper on Ankyrin repeat domain 18F, pseudogene (ANKRD18FP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ankyrin repeat domain 18F, pseudogene (ANKRD18FP).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call